Latest filing published 18 Jan 2023 for RepliCel Life Sciences Inc., €18k.
This profile gathers the share dealings of Peter Lowry in RepliCel Life Sciences Inc. The record holds 5 filings, for trades running from 15 January 2019 to 17 January 2023.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 18 January 2023 came the latest disclosure, a transaction for €18k in RepliCel Life Sciences Inc. Typically, a trade is published a median of 1 day after it takes place. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations